Rani Therapeutics Holdings, Inc.
RANI
$0.508
-$0.0059-1.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.20M | 1.03M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20M | 1.03M | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.20M | 1.03M | -- | -- | -- |
| SG&A Expenses | 23.11M | 23.95M | 24.31M | 25.32M | 26.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.78M | 50.63M | 51.79M | 57.85M | 63.62M |
| Operating Income | -47.58M | -49.60M | -51.79M | -57.85M | -63.62M |
| Income Before Tax | -54.54M | -56.58M | -54.92M | -60.53M | -65.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.54 | -56.58 | -54.92 | -60.53 | -65.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 24.74M | 26.57M | 26.75M | 29.94M | 32.75M |
| Net Income | -29.80M | -30.02M | -28.17M | -30.58M | -33.08M |
| EBIT | -47.58M | -49.60M | -51.79M | -57.85M | -63.62M |
| EBITDA | -46.55M | -48.57M | -50.80M | -56.90M | -62.74M |
| EPS Basic | -0.98 | -1.06 | -1.06 | -1.18 | -1.29 |
| Normalized Basic EPS | -0.23 | -0.24 | -0.28 | -0.30 | -0.33 |
| EPS Diluted | -0.98 | -1.06 | -1.06 | -1.18 | -1.29 |
| Normalized Diluted EPS | -0.23 | -0.24 | -0.28 | -0.30 | -0.33 |
| Average Basic Shares Outstanding | 121.26M | 113.85M | 107.07M | 103.78M | 102.81M |
| Average Diluted Shares Outstanding | 121.26M | 113.85M | 107.07M | 103.78M | 102.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |